Events & Presentations

American Society of Clinical Oncology (ASCO) 2017 Annual Meeting - Chicago, Illinois

Jun 2–6, 2017
12:00 AM

Additional Information

Title: Activity of RX-3117, an oral antimetabolite nucleoside, in subjects with metastatic bladder cancer resistant to gemcitabine: Preliminary results of a phase Ib/IIa study [View Poster]

Remind Me



©2017 by Rexahn Pharmaceuticals, Inc. All rights reserved
Rexahn Pharmaceuticals, Inc. - 15245 Shady Grove Road, Suite 455 - Rockville, MD 20850

Terms of Use
Privacy Policy